Literature DB >> 18756085

Treatment of vascular dementia: the route of prevention.

G Sorrentino1, R Migliaccio, V Bonavita.   

Abstract

Vascular dementia (VaD), rather than being considered as a univocal nosological entity, should be regarded as a heterogeneous clinical entity which differs in clinical-pathological phenotype as well as in pathophysiological mechanisms, but shares cerebrovascular disease (CVD), resulting from vascular or circulatory pathology, as the cause of dementia. The aim of this review is to discuss VaD treatment focusing particularly on more prevalent ischemic forms. Due to the fact that there are presently no treatments capable of obtaining considerable results once VaD is clinically established, specific emphasis will be given to the therapeutic strategies aimed at the prevention of CVD risk factors. The therapeutic strategies aimed at slowing the progression of the disease will also be discussed. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18756085     DOI: 10.1159/000151696

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

Review 1.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

2.  Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer's Disease.

Authors:  Arianna Polverino; Manuela Grimaldi; Pierpaolo Sorrentino; Francesca Jacini; Anna Maria D'Ursi; Giuseppe Sorrentino
Journal:  Cell Mol Neurobiol       Date:  2017-10-09       Impact factor: 5.046

3.  Systematic review on the efficacy and safety of herbal medicines for vascular dementia.

Authors:  Sui Cheung Man; Kam Wa Chan; Jia-Hong Lu; Siva Sundara Kumar Durairajan; Liang-Feng Liu; Min Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-20       Impact factor: 2.629

4.  Prevalence and Risk Factors of Comorbidities among Hypertensive Patients in China.

Authors:  Jiaojiao Wang; Jian James Ma; Jiaqi Liu; Daniel Dajun Zeng; Cynthia Song; Zhidong Cao
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

5.  Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2.

Authors:  Xian-Qin Luo; Ao Li; Xue Yang; Xiao Xiao; Rong Hu; Tian-Wen Wang; Xiao-Yun Dou; Da-Jian Yang; Zhi Dong
Journal:  Chin Med       Date:  2018-03-20       Impact factor: 5.455

6.  Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-γ-mediated microglial polarization.

Authors:  Hui Liu; Caixia Zang; Junmei Shang; Zihong Zhang; Lu Wang; Hanyu Yang; Chanjuan Sheng; Fangyu Yuan; Cheng Ju; Fangyuan Li; Yang Yu; Xinsheng Yao; Xiuqi Bao; Dan Zhang
Journal:  Food Nutr Res       Date:  2022-07-19       Impact factor: 3.221

7.  Electric stimulation of the ears ameliorated learning and memory impairment in rats with cerebral ischemia-reperfusion injury.

Authors:  Ching-Tung Kuo; Yi-Wen Lin; Nou-Ying Tang; Chin-Yi Cheng; Ching-Liang Hsieh
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

8.  Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia.

Authors:  Qiang You; Lan Li; Su-Qin Xiong; Yu-Fen Yan; Dan Li; Na-Na Yan; Hong-Ping Chen; You-Ping Liu
Journal:  Front Aging Neurosci       Date:  2019-04-17       Impact factor: 5.750

Review 9.  Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review.

Authors:  Anna B Marcinkowska; Natalia D Mankowska; Jacek Kot; Pawel J Winklewski
Journal:  Neuropsychol Rev       Date:  2021-04-13       Impact factor: 7.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.